Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Bio-Path Holdings, Inc. (BPTH)

Bone Biologics Corp. and Bio-Path Holdings, Inc. are both Biotechnology companies. Bone Biologics Corp. and Bio-Path Holdings, Inc. are of similar size ($1.1M and $1.1M). Across the 7 metrics below, Bio-Path Holdings, Inc. leads on 4 and Bone Biologics Corp. on 3.

Valuation

Metric BBLG BPTH Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.20 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.00 0.66
EV/Sales n/m n/m 9.02
Earnings yield (438.22%) 0.00% (32.88%)
Free cash flow yield (214.89%) 0.00% (23.13%)

Profitability

Metric BBLG BPTH Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.49%) 157.01% (51.96%)
Return on assets (44.46%) (605.50%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG BPTH Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 90.85% 87.75% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG BPTH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.38 0.07 4.97
Net debt to EBITDA 1.65 0.10 1.01

Dividend

Metric BBLG BPTH Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBLG BPTH Biotechnology median
Market cap 1.10m 1.07m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack